Literature DB >> 12137647

Physical training for bronchiectasis.

J Bradley1, F Moran, M Greenstone.   

Abstract

BACKGROUND: The pathophysiology of bronchiectasis may result in the development of dyspnoea and decreased exercise tolerance, both of which can impact on a patient's quality of life and ability to perform activities of daily living. There is little information regarding the benefits of physical training in bronchiectasis: however it is probable that the benefits of physical training in bronchiectasis are at least comparable to benefits demonstrated in other respiratory conditions. There is also no information regarding the effects of non-adherence to prescribed physical training in bronchiectasis. However as in patients with COPD non-adherence may contribute to a deterioration in the patient's condition and conceivably the long term prognosis.
OBJECTIVES: The objective of this review is to determine whether a prescribed regime of physical training produces improvements or prevents deterioration in physiological and clinical outcomes in bronchiectasis compared to no physical training. SEARCH STRATEGY: We searched the Cochrane Airways Group specialised register and the Cochrane Controlled Clinical Trials Register. SELECTION CRITERIA: Randomised or quasi randomised controlled trials in which a prescribed regime of physical training are compared to no physical training in patients with bronchiectasis. DATA COLLECTION AND ANALYSIS: Three studies were identified. One was did not meet the inclusion criteria and two appeared in abstract form only. More comprehensive data will be incorporated into this review once data from those two trials are published, and when further data is made available to the authors of this review. MAIN
RESULTS: Results from the two studies published in abstract showed that inspiratory muscle training compared to sham or no inspiratory muscle training improved endurance exercise capacity: Weighted Mean Difference (WMD) 264 metres (95% CI 16.4 to 512 metres). PiMax improved: WMD 25 cms H20 (95% CI 11.6 to 38.4 cms H2O )as did quality of life measured with the CRQ: WMD 12.4 units (95% CI 2.4 to 22.5 units). REVIEWER'S
CONCLUSIONS: This review only provides evidence of the benefits of inspiratory muscle training and provides no evidence of the effect of other types of physical training (including pulmonary rehabilitation) in bronchiectasis.

Entities:  

Mesh:

Year:  2002        PMID: 12137647      PMCID: PMC7017844          DOI: 10.1002/14651858.CD002166

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  4 in total

1.  Respiratory muscle training in chronic airflow limitation: a meta-analysis.

Authors:  K Smith; D Cook; G H Guyatt; J Madhavan; A D Oxman
Journal:  Am Rev Respir Dis       Date:  1992-03

2.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

3.  The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease.

Authors:  S M Revill; M D Morgan; S J Singh; J Williams; A E Hardman
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

4.  Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis.

Authors:  F Kellett; J Redfern; R McL Niven
Journal:  Respir Med       Date:  2005-01       Impact factor: 3.415

  4 in total
  13 in total

Review 1.  Interventions for bronchiectasis: an overview of Cochrane systematic reviews.

Authors:  Emma J Welsh; David J Evans; Stephen J Fowler; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2015-07-14

2.  Treating Cough Due to Non-CF and CF Bronchiectasis With Nonpharmacological Airway Clearance: CHEST Expert Panel Report.

Authors:  Adam T Hill; Alan F Barker; Donald C Bolser; Paul Davenport; Belinda Ireland; Anne B Chang; Stuart B Mazzone; Lorcan McGarvey
Journal:  Chest       Date:  2018-01-31       Impact factor: 9.410

3.  The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial.

Authors:  Annemarie L Lee; Nola Cecins; Catherine J Hill; Anne E Holland; Linda Rautela; Robert G Stirling; Phillip J Thompson; Christine F McDonald; Sue Jenkins
Journal:  BMC Pulm Med       Date:  2010-02-02       Impact factor: 3.317

4.  Could vitamin d have a potential anti-inflammatory and anti-infective role in bronchiectasis?

Authors:  Jim Bartley; Jeff Garrett; Cameron C Grant; Carlos A Camargo
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 5.  Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.

Authors:  M D Tarzi; S Grigoriadou; S B Carr; L M Kuitert; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

Review 6.  Primary ciliary dyskinesia: current state of the art.

Authors:  Andrew Bush; Rahul Chodhari; Nicola Collins; Fiona Copeland; Pippa Hall; Jonny Harcourt; Mohamed Hariri; Claire Hogg; Jane Lucas; Hannah M Mitchison; Christopher O'Callaghan; Gill Phillips
Journal:  Arch Dis Child       Date:  2007-07-18       Impact factor: 3.791

Review 7.  An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses.

Authors:  Chris D Bailey; Richard Wagland; Rasha Dabbour; Ann Caress; Jaclyn Smith; Alex Molassiotis
Journal:  BMC Pulm Med       Date:  2010-12-09       Impact factor: 3.317

8.  Exercise training for bronchiectasis.

Authors:  Annemarie L Lee; Carla S Gordon; Christian R Osadnik
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06

9.  Genetics, diagnosis, and future treatment strategies for primary ciliary dyskinesia.

Authors:  M Leigh Anne Daniels; Peadar G Noone
Journal:  Expert Opin Orphan Drugs       Date:  2014-11-29       Impact factor: 0.694

Review 10.  Airway disease: similarities and differences between asthma, COPD and bronchiectasis.

Authors:  Rodrigo Athanazio
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.